Gansu Longshenrongfa Pharmaceutical Industry(300534.SZ): Tongmai Oral Liquid Approved for Listing and Sales

Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., has obtained the "Drug Pre-Market Site Inspection and First Batch Product Inspection Registration Document" issued by the Gansu Provincial Drug Administration. The Tongmai Oral Liquid has passed the on-site inspection of drug production, technical evaluation, and the sampled product (batch number: CP022250701) has been tested by the provincial drug testing institute to meet the regulations and can be marketed. Tongmai Oral Liquid is used for promoting blood circulation, relieving blood vessel blockages, and treating ischemic cardiovascular and cerebrovascular diseases, arteriosclerosis, cerebral thrombosis, cerebral ischemia, angina, and other related conditions.